What is the ROCE (Return on Capital Employed) of Zynex this year?
The ROCE of Zynex is 0.17 undefined this year.
Zynex ROCE 2025
Zynex ROCE
0.17
Ticker
ZYXI
ISIN
US98986M1036
WKN
A0Q5XP
In 2025, Zynex's return on capital employed (ROCE) was 0.17, a -28.22% increase from the 0.23 ROCE in the previous year.
Zynex Aktienanalyse
What does Zynex do?
Zynex Inc is an American company that manufactures and distributes medical devices and accessories. The company was founded in 1996 and is headquartered in Englewood, Colorado. In recent years, it has become a major player in the pain therapy market. The history of Zynex began with the development of a neurotherapeutic system called NeuroMove, which aimed to restore mobility in patients with paralysis after strokes or other neurological disorders. The company uses proprietary technology to provide safe and effective electrotherapeutic stimulation, which helps trigger muscle contractions and improve mobility. Over the years, the company has specialized in the development and sale of medical devices for pain therapy and rehabilitation. Zynex's products can be used in various areas, including electrostimulation, TENS and EMS therapy, home diagnostics, as well as blood pressure and oxygen measurement. Zynex offers devices specifically for pain therapy. These devices are used by many doctors and physiotherapists to support patients in their healing process. The company's flagship product is the Nexus D-11 EMS and TENS device, which is capable of conducting multiple pain treatments simultaneously. Another important device from Zynex is the InWave system, which applies FDA-approved electromagnetic wave therapy. The therapy is used for both acute and chronic pain and aims to promote the body's natural healing processes to relieve pain. Zynex also manufactures home diagnostic devices such as the blood sugar monitor and pulse oximeter, which can be regularly used by patients at home to monitor their well-being. These products help individuals develop an understanding of how their body responds to different treatments or environmental conditions. An important aspect of Zynex's business model is collaborating with healthcare customers. The company forms partnerships with medical facilities and practitioners to ensure that its products are effectively and safely utilized. These partnerships often include training programs to ensure that users of each device develop a basic understanding of how it works to ensure quality treatment. Zynex has also established a subsidiary called Zynex Medical Europe, which operates in European regions. The company is based in the Netherlands and is responsible for marketing and distributing Zynex's products in Europe. Overall, Zynex has established itself as a key player in the field of pain therapy and rehabilitation. Through its innovative technology and healthcare partnerships, the company is able to provide the best possible patient care. Zynex ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Zynex's Return on Capital Employed (ROCE)
Zynex's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Zynex's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Zynex's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Zynex’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Zynex stock
How has the ROCE (Return on Capital Employed) of Zynex developed compared to the previous year?
The ROCE of Zynex has increased by -28.22% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Zynex?
A high Return on Capital Employed (ROCE) indicates that Zynex has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Zynex?
A low ROCE (Return on Capital Employed) can indicate that Zynex has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Zynex impact the company?
An increase in the ROCE of Zynex can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Zynex affect the company?
A decrease in ROCE of Zynex can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Zynex?
Some factors that can affect Zynex's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Zynex so important for investors?
The ROCE of Zynex is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Zynex take to improve the ROCE?
To improve the ROCE, Zynex can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Zynex pay?
Over the past 12 months, Zynex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zynex is expected to pay a dividend of -0.11 USD.
What is the dividend yield of Zynex?
The current dividend yield of Zynex is .
When does Zynex pay dividends?
Zynex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zynex?
Zynex paid dividends every year for the past 1 years.
What is the dividend of Zynex?
For the upcoming 12 months, dividends amounting to -0.11 USD are expected. This corresponds to a dividend yield of -7.8 %.
In which sector is Zynex located?
Zynex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zynex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zynex from 1/21/2022 amounting to 0.1 USD, you needed to have the stock in your portfolio before the ex-date on 1/5/2022.
When did Zynex pay the last dividend?
The last dividend was paid out on 1/21/2022.
What was the dividend of Zynex in the year 2024?
In the year 2024, Zynex distributed 0 USD as dividends.
In which currency does Zynex pay out the dividend?
The dividends of Zynex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zynex
Our stock analysis for Zynex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zynex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
